Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.69
+0.28 (1.06%)
Nov 18, 2026, 4:00 PM EST - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.75 billion as of November 18, 2026. It is the 7,043rd most valuable company in the world and the 1,824th biggest in the United States. Its market cap has increased by 13.41% in one year.
Market Cap
1.75B
Enterprise Value
1.39B
1-Year Change
13.41%
Global Rank
Country Rank
#1,824 United States
Category
ChartMarket Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.75B, an increase of 117.00%. That is a compound annual growth rate of 11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 1.75B | -3.71% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.85B |
| Zymeworks | 1.83B |
| Hemab Therapeutics Holdings | 1.83B |
| Recursion Pharmaceuticals | 1.81B |
| Agios Pharmaceuticals | 1.80B |
| Mesoblast | 1.65B |
| Lycia Therapeutics | 1.65B |
| Vir Biotechnology | 1.64B |